Initially, AIM2 was identified as a tumor suppressor in melanoma and colorectal cancer [16], but other studies on tumor-derived DNA [8,9], have demonstrated the pro-tumor activity of AIM2, as also demonstrated by our laboratory [12,17,18,19,20]. The gene discussed is AIM2; the disease is colorectal cancer.